PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRFX PainReform

Trading 11-01 10:33:01 EDT

0.4900

-0.0100

-2.00%

High0.5000	Low0.4823	Vol36.55K
Open0.4850	D1 Closing0.5000	Amplitude3.54%
Mkt Cap1.09M	Tradable Cap1.08M	Total Shares2.23M
T/O17.96K	T/O Rate1.66%	Tradable Shares2.21M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PRFX","market":"US","secType":"STK","nameCN":"PainReform","latestPrice":0.49,"timestamp":1730471091686,"preClose":0.5,"halted":0,"volume":36551,"delay":0,"floatShares":2207900,"shares":2226452,"eps":-30.573956,"marketStatus":"Trading","change":-0.01,"latestTime":"11-01 10:33:01 EDT","open":0.485,"high":0.5,"low":0.4823,"amount":17955.99381962,"amplitude":0.0354,"askPrice":0.5,"askSize":200,"bidPrice":0.4808,"bidSize":40,"shortable":0,"etf":0,"ttmEps":-30.573956,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1730491200000},"marketStatusCode":2,"adr":0,"listingDate":1598932800000,"exchange":"NASDAQ","adjPreClose":0.5,"preHourTrading":{"tag":"盘前","latestPrice":0.4948,"preClose":0.5,"latestTime":"09:26 EDT","volume":4262,"amount":2062.9765621,"timestamp":1730467576583},"postHourTrading":{"tag":"盘后","latestPrice":0.4948,"preClose":0.5,"latestTime":"19:18 EDT","volume":17877,"amount":8646.6738,"timestamp":1730416719073},"volumeRatio":1.525643},"requestUrl":"/m/hq/s/PRFX","defaultTab":"news","newsList":[{"id":"2477656296","title":"Maxim Downgrades PainReform to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2477656296","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477656296?lang=en_us&edition=fundamental","pubTime":"2024-10-24 23:15","pubTimestamp":1729782959,"startTime":"0","endTime":"0","summary":"Price: 0.71, Change: -0.03, Percent Change: -3.44","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRFX"],"gpt_icon":0},{"id":"2477984631","title":"PainReform Cut to Hold From Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2477984631","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477984631?lang=en_us&edition=fundamental","pubTime":"2024-10-24 21:43","pubTimestamp":1729777380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRFX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 24, 2024 09:43 ET (13:43 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2477063133","title":"PainReform cut to Hold at Maxim amid ‘changed’ market dynamics","url":"https://stock-news.laohu8.com/highlight/detail?id=2477063133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477063133?lang=en_us&edition=fundamental","pubTime":"2024-10-24 21:25","pubTimestamp":1729776316,"startTime":"0","endTime":"0","summary":"As previously reported, Maxim analyst Naz Rahman downgraded PainReform (PRFX) to Hold from Buy. The company is developing PRF-110 to treat post-ope...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-cut-to-hold-at-maxim-amid-changed-market-dynamics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-cut-to-hold-at-maxim-amid-changed-market-dynamics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2477682303","title":"PainReform downgraded to Hold from Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2477682303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477682303?lang=en_us&edition=fundamental","pubTime":"2024-10-24 19:55","pubTimestamp":1729770907,"startTime":"0","endTime":"0","summary":"Maxim analyst Naz Rahman downgraded PainReform (PRFX) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-movin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-downgraded-to-hold-from-buy-at-maxim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-downgraded-to-hold-from-buy-at-maxim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX"],"gpt_icon":0},{"id":"2477681896","title":"PainReform Ltd : Maxim Group Cuts to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2477681896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477681896?lang=en_us&edition=fundamental","pubTime":"2024-10-24 19:37","pubTimestamp":1729769843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241024:nFWN3M012D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2476715579","title":"PainReform Announces Significant Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2476715579","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476715579?lang=en_us&edition=fundamental","pubTime":"2024-10-17 04:57","pubTimestamp":1729112254,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) has released an update. PainReform Ltd., an Israeli company, is set to offer and sell up to $1.35 million in ordinary shares thro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-announces-significant-share-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-announces-significant-share-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2476979106","title":"PainReform Ltd: Co Entered Into Market Offering Agreement With H.c. Wainwright & Co., Llc","url":"https://stock-news.laohu8.com/highlight/detail?id=2476979106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476979106?lang=en_us&edition=fundamental","pubTime":"2024-10-17 04:51","pubTimestamp":1729111916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241016:nFWN3LS1CF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2476497135","title":"PainReform Ltd: Co to Offer and Sell From Time to Time Through Wainwright's Ordinary Shares of Company at Offering Price of $1.35 Mln Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2476497135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476497135?lang=en_us&edition=fundamental","pubTime":"2024-10-17 04:51","pubTimestamp":1729111916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241016:nFWN3LS1CF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2474708187","title":"PainReform Calls Shareholder Meeting for Key Votes","url":"https://stock-news.laohu8.com/highlight/detail?id=2474708187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474708187?lang=en_us&edition=fundamental","pubTime":"2024-10-11 05:43","pubTimestamp":1728596623,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) has released an update. PainReform Ltd. has announced a Special Meeting of Shareholders scheduled for November 4, 2024, to vote o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-calls-shareholder-meeting-for-key-votes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-calls-shareholder-meeting-for-key-votes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2473910434","title":"PainReform Shareholders Approve All Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2473910434","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473910434?lang=en_us&edition=fundamental","pubTime":"2024-10-08 05:28","pubTimestamp":1728336504,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) has released an update. PainReform Ltd. successfully passed all eight shareholder proposals at their Annual General Meeting on Oc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-shareholders-approve-all-proposals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-shareholders-approve-all-proposals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2466235957","title":"BRIEF-PainReform Confirms Sutures Compatibility In Human Clinical Trials For PRF-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2466235957","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466235957?lang=en_us&edition=fundamental","pubTime":"2024-09-11 23:08","pubTimestamp":1726067311,"startTime":"0","endTime":"0","summary":"Sept 11  - PainReform Ltd   :   * PAINREFORM LTD. CONFIRMS SUTURES COMPATIBILITY IN HUMAN CLINICAL TRIALS FOR PRF-110   * PAINREFORM LTD - PRF-110 DOES NOT IMPACT MECHANICAL PROPERTIES OF PROLENE OR VICRYL SUTURES   * PAINREFORM LTD - FINDINGS CONSISTENT WITH PHASE III BUNIONECTOMY TRIAL RESULTSSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","PRFX","PRF","BK4588"],"gpt_icon":0},{"id":"2466280639","title":"PainReform Ltd. Launches Warrant Exercise Incentive Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2466280639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466280639?lang=en_us&edition=fundamental","pubTime":"2024-09-11 21:57","pubTimestamp":1726063056,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) has released an update. PainReform Ltd. is making a strategic inducement offer to warrant holders, providing an opportunity to pu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-ltd-launches-warrant-exercise-incentive-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-ltd-launches-warrant-exercise-incentive-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2466856762","title":"PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for Prf-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2466856762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466856762?lang=en_us&edition=fundamental","pubTime":"2024-09-11 20:30","pubTimestamp":1726057801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240911:nTUA3MWLB2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2466851862","title":"PainReform Ltd - Findings Consistent With Phase Iii Bunionectomy Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2466851862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466851862?lang=en_us&edition=fundamental","pubTime":"2024-09-11 20:30","pubTimestamp":1726057801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240911:nTUA3MWLB2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2466428518","title":"PainReform Ltd - Prf-110 Does Not Impact Mechanical Properties of Prolene or Vicryl Sutures","url":"https://stock-news.laohu8.com/highlight/detail?id=2466428518","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466428518?lang=en_us&edition=fundamental","pubTime":"2024-09-11 20:30","pubTimestamp":1726057801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240911:nTUA3MWLB2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2466859022","title":"PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2466859022","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466859022?lang=en_us&edition=fundamental","pubTime":"2024-09-11 20:30","pubTimestamp":1726057800,"startTime":"0","endTime":"0","summary":"Positive Compatibility Results Reinforce Safety and Efficacy of PRF-110 in Post-Surgical Pain ManagementTEL AVIV, Israel, Sept.  11, 2024  (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (\"PainRefo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/11/2944474/0/en/PainReform-Ltd-Confirms-Sutures-Compatibility-in-Human-Clinical-Trials-for-PRF-110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","PRFX","PRF","BK4585"],"gpt_icon":0},{"id":"2466146241","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2466146241","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466146241?lang=en_us&edition=fundamental","pubTime":"2024-09-11 02:24","pubTimestamp":1725992669,"startTime":"0","endTime":"0","summary":"PainReform  said it signed definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to 989,300 of its shares at a reduced exercise price of $1.60 apiece.The company originally issued the shares in December 2023 and April 2024, with an exercise price of $4.80 per share.Shares of the healthcare company slumped 33%, with intraday trading volume at over 637,000 compared with a daily average of about 213,000.Hewlett Packard Enterprise  late on Monday unveiled a $1.35 billion offering of convertible preferred shares.Shares of the technology giant dropped 6.3% as intraday trading volume rose to over 29.3 million versus a daily average of about 14.2 million.JPMorgan Chase  shares dropped 5.3% after Chief Operating Officer Daniel Pinto said that expectations for the bank's 2025 net interest income \"are a bit too high,\" according to a Capital IQ transcript.More than 20.7 million shares of the financial service behemoth traded intraday compared with a daily ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1496350502.SGD","LU1032466523.USD","BK4581","BK4588","LU","LU0323591593.USD","IE00BFXG1179.USD","LU0234572021.USD","LU1496350171.SGD","LU0496365809.HKD","LU0215105999.USD","LU0310799852.SGD","LU1668664300.SGD","IE00BJTD4N35.SGD","IE00BWXC8680.SGD","LU0149725797.USD","LU0971096721.USD","LU0238689110.USD","BK4585","LU1244550221.USD","LU0203345920.USD","LU0882574139.USD","LU0170899867.USD","BK4566","LU1084165304.USD","IE00BJTD4V19.USD","IE00BLSP4452.SGD","LU1119994496.HKD","LU1363072403.SGD","LU1267930490.SGD","LU1064131342.USD","PRFX","IE0034235188.USD","LU1244550494.USD","HPE","LU0976567544.SGD","LU0211331839.USD","LU0417517546.SGD","BK4007","LU0211328371.USD","BK4515","LU0320765489.SGD","LU0070302665.USD","LU1162221912.USD","BK4550","BK4207","IE00BKVL7J92.USD","IE00BHPRN162.USD","BK4533","IE00B775SV38.USD"],"gpt_icon":0},{"id":"2466578384","title":"PainReform to Exercise Warrants for $1.6 Million in Gross Proceeds; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2466578384","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466578384?lang=en_us&edition=fundamental","pubTime":"2024-09-10 23:13","pubTimestamp":1725981195,"startTime":"0","endTime":"0","summary":"PainReform  said Tuesday it entered into agreements to immediately exercise certain warrants to buy up to 989,300 ordinary shares.These shares were originally issued in December 2023 and April 2024. Their exercise price will be reduced to $1.60 per share from $4.80, the company said, adding that the offering is set to close around Wednesday.In exchange for this immediate exercise, PainReform will issue new warrants to buy up to nearly 2 million ordinary shares at $1.60 per share. These new warrants will expire in five years, the company said.Gross proceeds are expected to be about $1.6 million. Net proceeds from the offering will be used for general corporate purposes, the company said.Shares of PainReform fell over 20% in recent trading activity.Price: 1.26, Change: -0.33, Percent Change: -20.75","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PRFX"],"gpt_icon":0},{"id":"2466457865","title":"PainReform to Exercise Warrants for $1.6 Million in Gross Proceeds; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2466457865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466457865?lang=en_us&edition=fundamental","pubTime":"2024-09-10 23:13","pubTimestamp":1725981195,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["PRFX","BK4007"],"gpt_icon":0},{"id":"2466095455","title":"PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2466095455","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466095455?lang=en_us&edition=fundamental","pubTime":"2024-09-10 21:46","pubTimestamp":1725975960,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Sept.  10, 2024  (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (\"PainReform\" or the \"Company\"), a clinical-stage specialty pharmaceutical company focused on the reformulation of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/10/2943812/0/en/PainReform-Announces-Exercise-of-Warrants-for-1-58-Million-Gross-Proceeds.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.painreform.com","stockEarnings":[{"period":"1week","weight":-0.2857},{"period":"1month","weight":-0.1955},{"period":"3month","weight":-0.7771},{"period":"6month","weight":-0.8985},{"period":"1year","weight":-0.963},{"period":"ytd","weight":-0.9697}],"compareEarnings":[{"period":"1week","weight":-0.0183},{"period":"1month","weight":0},{"period":"3month","weight":0.0671},{"period":"6month","weight":0.1122},{"period":"1year","weight":0.3454},{"period":"ytd","weight":0.1964}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.055707},{"month":2,"riseRate":0.5,"avgChangeRate":0.138423},{"month":3,"riseRate":0.5,"avgChangeRate":-0.007289},{"month":4,"riseRate":0,"avgChangeRate":-0.300309},{"month":5,"riseRate":0,"avgChangeRate":-0.127434},{"month":6,"riseRate":0.5,"avgChangeRate":-0.034279},{"month":7,"riseRate":0.5,"avgChangeRate":-0.026582},{"month":8,"riseRate":0.25,"avgChangeRate":-0.202384},{"month":9,"riseRate":0.25,"avgChangeRate":-0.207842},{"month":10,"riseRate":0,"avgChangeRate":-0.170305},{"month":11,"riseRate":0.5,"avgChangeRate":-0.073208},{"month":12,"riseRate":0.25,"avgChangeRate":-0.07605}],"exchange":"NASDAQ","name":"PainReform","nameEN":"PainReform"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PainReform(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PainReform,PRFX,PainReform股票,PainReform股票老虎,PainReform股票老虎国际,PainReform行情,PainReform股票行情,PainReform股价,PainReform股市,PainReform股票价格,PainReform股票交易,PainReform股票购买,PainReform股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PainReform(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PainReform(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}